Elephas will collaborate with the Mayo Clinic Comprehensive Cancer Center to develop of oncology imaging diagnostics platform that will predict response to immunotherapy, the company announced today. “We are excited…

Elephas has closed a $55 million Series C funding round led by Venture Investors Health Fund and State of Wisconsin Investment Board (SWIB), the company announced today. “We remain intensely…

Elephas Biosciences Corporation, a biotech company that developed an oncology diagnostics platform to predict response to immunotherapy, has raised $41.5 million in a Series B funding round, the company announced…